NLS Pharmaceutics Ltd. Quarterly Common Stock, Shares Authorized from Q4 2019 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
NLS Pharmaceutics Ltd. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2019 to Q2 2023.
  • NLS Pharmaceutics Ltd. Common Stock, Shares Authorized for the quarter ending June 30, 2023 was 35.7M shares, a 21.6% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 35.7M +6.33M +21.6% Jun 30, 2023 6-K 2023-12-06
Q4 2022 35.7M +6.33M +21.6% Dec 31, 2022 6-K 2023-12-06
Q2 2022 29.3M +11.4M +63.5% Jun 30, 2022 6-K 2022-10-11
Q4 2021 29.3M +11.4M +63.5% Dec 31, 2021 6-K 2022-10-11
Q2 2021 17.9M Jun 30, 2021 6-K 2021-09-28
Q4 2020 17.9M +7.51M +71.9% Dec 31, 2020 6-K 2021-09-28
Q4 2019 10.4M Dec 31, 2019 20-F 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.